| Market Cap | 0.94B | P/E | 175.35 | EPS this Y | -22.80% | Ern Qtrly Grth | - |
| Income | -20.97M | Forward P/E | -45.83 | EPS next Y | 8.80% | 50D Avg Chg | -8.00% |
| Sales | 148.73M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -8.00% |
| Dividend | N/A | Price/Book | 2.48 | EPS next 5Y | - | 52W High Chg | -34.00% |
| Recommedations | 2.00 | Quick Ratio | 2.76 | Shares Outstanding | 23.79M | 52W Low Chg | 13.00% |
| Insider Own | 31.90% | ROA | -3.72% | Shares Float | 16.04M | Beta | 1.18 |
| Inst Own | 71.64% | ROE | -5.55% | Shares Shorted/Prior | 0.98M/0.94M | Price | 40.33 |
| Gross Margin | 74.80% | Profit Margin | -14.10% | Avg. Volume | 85,196 | Target Price | 40.00 |
| Oper. Margin | -21.45% | Earnings Date | May 6 | Volume | 122,659 | Change | 1.50% |
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
| Needham | Buy | Apr 10, 24 |
| Truist Securities | Hold | Mar 8, 24 |
| Stifel | Buy | Mar 7, 24 |
| Needham | Buy | Mar 7, 24 |
| JMP Securities | Market Outperform | Mar 7, 24 |
| Truist Securities | Hold | Jan 25, 24 |
| Truist Securities | Buy | Dec 22, 23 |
| JMP Securities | Market Outperform | Dec 7, 23 |
| Truist Securities | Buy | Nov 8, 23 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Schlotterback Terry D | Director Director | Aug 07 | Option | 30.97 | 670 | 20,750 | 18,591 | 08/09/23 |
| Odle Gregory A | President of Scolios.. President of Scoliosis | Apr 21 | Sell | 50.0185 | 644 | 32,212 | 87,402 | 04/24/23 |
| Bailey David R | President and CEO President and CEO | Mar 06 | Sell | 44.4004 | 4,052 | 179,910 | 100,453 | 03/07/23 |
| Hite Fred | COO and CFO COO and CFO | Mar 06 | Sell | 43.766 | 4,099 | 179,397 | 71,623 | 03/07/23 |
| Odle Gregory A | Executive Vice Presi.. Executive Vice President | Mar 06 | Sell | 44.0276 | 3,421 | 150,618 | 68,429 | 03/07/23 |
| Throdahl Mark C | Director Director | Mar 06 | Sell | 43.8254 | 4,515 | 197,872 | 128,024 | 03/07/23 |
| Gerritzen Daniel J | General Counsel and.. General Counsel and Secretary | Mar 06 | Sell | 44.6203 | 3,315 | 147,916 | 35,527 | 03/07/23 |
| Odle Gregory A | Executive Vice Presi.. Executive Vice President | Jan 13 | Sell | 45 | 1,771 | 79,695 | 73,125 | 01/17/23 |
| Odle Gregory A | Executive Vice Presi.. Executive Vice President | Jan 09 | Sell | 45.0437 | 229 | 10,315 | 74,896 | 01/10/23 |
| Ruf Harold | Director Director | Jun 16 | Buy | 39.45 | 1,235 | 48,721 | 13,824 | 06/16/22 |
| Hauser Joseph W | Sr VP & GM Trauma &.. Sr VP & GM Trauma & Deformity | Feb 07 | Sell | 46.04 | 3,220 | 148,249 | 26,698 | 03/03/22 |
| Odle Gregory A | Executive Vice Presi.. Executive Vice President | Mar 02 | Sell | 57.55 | 4,108 | 236,415 | 62,761 | 03/03/22 |
| Pritzker Jennifer N. | 10% Owner 10% Owner | Dec 09 | Buy | 59.82 | 2,500 | 149,550 | 707 | 12/13/21 |